Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer

Testing for 1 or more single nucleotide variants to predict an individual’s risk of breast cancer is considered investigational.

The GeneType® breast cancer risk test is considered investigational for all indications, including but not limited to use as a method of estimating individual risk for developing breast cancer.